Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q1 2024 Earnings Conference Call May 9, 2024 8:30 AM ET

Company Participants

Garth Russell – LifeSci Advisors
Jon Congleton – Chief Executive Officer
Adam Levy – Chief Financial Officer
David Rodman – Chief Medical Officer

Conference Call Participants

Jack Padovano – Stifel
Seamus Fernandez – Guggenheim Securities
Michael DiFiore – Evercore
Rami Katkhuda – LifeSci Capital
Rich Law – Goldman Sachs
Mohit Bansal – Wells Fargo

Operator

Good morning, ladies and gentlemen, and welcome to the Mineralys First Quarter 2024 Earnings Conference Call. At this time all lines are in listen-only mode. Following the presentation, we will conduct a question-and-answer session. [Operator Instructions] This call is being recorded on Thursday, May 9, 2024.

I would now like to turn the conference over to Garth Russell of LifeSci Advisors. Please go ahead.

Garth Russell

Thank you, operator. Good morning, everyone, and welcome to our first quarter 2024 conference call. Earlier this morning, we issued a press release providing our first quarter 2024 financial results and business updates. A replay of today's call will be available on the Investors section of our website approximately one hour after its completion. After our prepared remarks, we will open up the call for Q&A.

Before we begin, I would like to remind everyone that this conference call and webcast will contain certain forward-looking statements about the company. Actual results could differ materially from those stated or implied by these forward-looking statements due to risks and uncertainties associated with the company's business. These forward-looking statements are qualified by the cautionary statements contained in today's press release and our SEC filings, including our annual report on Form 10-K and subsequent filings. Please note that these forward-looking statements reflect our opinions only as of today, May 9. Except as required by law, we specifically disclaim any obligation to update or revise these forward-looking statements in light of new information or future events.

I would now like to turn the call over to Jon Congleton, Chief Executive Officer, Mineralys. Jon?

Jon Congleton

Thank you, Garth. Good morning, everyone. Welcome to our first quarter 2024 financial results and corporate update conference call. I'm joined today by Adam Levy, our Chief Financial Officer; and Dr. David Rodman, our Chief Medical Officer. Considering the relatively short period of time between this call and our fourth quarter call, we're going to keep our prepared remarks today fairly brief.